Recent advances in CT and nuclear medicine will take center stageat Elscint's RSNA booth. In CT, the Israeli firm will introduceSeleCT/SP, a new entry-level spiral CT platform targeted at developingcountries. SeleCT/SP is a compact 1.8-second scanner
Recent advances in CT and nuclear medicine will take center stageat Elscint's RSNA booth. In CT, the Israeli firm will introduceSeleCT/SP, a new entry-level spiral CT platform targeted at developingcountries.
SeleCT/SP is a compact 1.8-second scanner that features solid-statedetectors, like Elscint's premium CT-Twin scanner. It can cover60 cm in a single 60-second spiral acquisition with resolutionof 12 lp/cm and a field-of-view of 485 mm.
MasterWorks is a new set of CT image processing techniques tobe shown for the first time. MasterCut enables clinicians to delineatea curve of interest along vessels or airways. MasterMatch is amultimodality image registration package, while MasterFilm allowsimages to be previewed and edited before printing.
In nuclear medicine, Elscint will highlight its digital Varicamadjustable-angle dual-head gamma camera, introduced earlier thisyear (SCAN 6/7/95). Elscint is awaiting 510(k) clearance for thecamera, according to Richard Brown, marketing manager.
The company's TransACT attenuation correction protocol, whichworks on both Varicam and the CardiaL 90° dual-head camera,recently received the Food and Drug Administration's nod. In nuclearmedicine image processing, Elscint will show a new version 4.0release of its XPert workstation software that supports new applications,including gated SPECT and image registration.
Elscint has beefed up its prowess in PACS with a sales and marketingagreement with Agfa. Elscint will integrate Agfa's Impax systemand its DryStar printer with its own products and will bring Agfasales reps into its sites where connectivity solutions are needed.Elscint recently formed a connectivity department to help integrateits products with those of other vendors using the DICOM 3.0 standard.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.